
TSE:PBH
This summary was created by AI, based on 18 opinions in the last 12 months.
Premium Brands Holdings Corp (PBH) has garnered mixed reviews from analysts regarding its recent performance and growth prospects. The company is viewed positively for its expansion efforts into the U.S. and its partnerships with major clients like Costco and Starbucks, which are expected to drive revenue growth despite potential economic headwinds. Some experts express concerns about high debt levels and aggressive accounting practices, with some recommending a cautious approach to investing. The stock saw a decline recently but is perceived to have strong management and a promising growth trajectory, leading to differing views on its short-term performance and long-term potential. Analysts have varied price targets, indicating differing opinions on its value relative to its current price.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company has potential but comes with more risk and the valuation is somewhat high. The recent deals that they have announced is solid and is positive for their future. Unlock Premium - Try 5i Free
The Clearwater acquisition offers good synergy. The partnership makes the deal less capital intensive. Part of the recovery trade with restaurant and hotel sales coming back. 22% EPS growth trading at 18x. Have made very good acquisitions and is good at integrating them. (Analysts’ price target is $116.82)
Long-term, they've done a great job in acquisitions. The recent one with Clearwater was the biggest though PBH was already in the seafood business. They'll continue to grow by acquisition and organically.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. - A balanced risk return ratio. It could see some good benefit when schools and universities are back to normal. Offers a nice risk based growth rate. Unlock Premium - Try 5i Free
They just announced joint acquisition of Clearwater SeaFoods. It brings harvesting into the organization. 90% of Clearwater's product is sold internationally while PBH-T sells only within Canada and the US. It turns them into a global player. (Analysts’ price target is $109.75)